首页 › 基金 › Cormorant Asset Management, LP › QNCX
Cormorant Asset Management, LP 对 QNCX 的持仓历史
QUINCE THERAPEUTICS INC · 医疗保健
Cormorant Asset Management, LP 在 Q2 2026 的 13F 申报中披露持有 QNCX(QUINCE THERAPEUTICS INC)5,498 股,市值约 US$100K,约占其申报组合的 0.01%,在其申报持仓中市值排名第 50 位。 Cormorant Asset Management, LP 于 Q2 2026 首次申报该持仓。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Cormorant Asset Management, LP 对 QNCX 的持仓演变
Cormorant Asset Management, LP 于 Q2 2026 首次披露 QNCX 持仓:5,498 股(约 US$100K)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 5.50K | $100.01K | 新进 |
关于 QNCX 与 13F 数据
QNCX(QUINCE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 19 只申报持有 QNCX,申报仓位最大的包括:Squadron Capital Management LLC (US$734K)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
更多关于 Cormorant Asset Management, LP
常见问题
How long has Cormorant Asset Management, LP held QNCX?
Cormorant Asset Management, LP has disclosed QNCX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Cormorant Asset Management, LP's current position in QNCX?
As of Q2 2026, Cormorant Asset Management, LP holds 5.50K shares of QNCX (QUINCE THERAPEUTICS INC), valued at $100.01K, representing 0.01% of its reported portfolio and ranking #50.
Has Cormorant Asset Management, LP been buying or selling QNCX?
In the latest 13F filing (Q2 2026), Cormorant Asset Management, LP newly opened its position in QNCX.
Which other funds hold QNCX?
Other major institutional holders of QNCX include Squadron Capital Management LLC, among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.